Picard Medical Q3 2026 Net Loss Narrows 79% to $2.2 Million

PUBT · 1d ago
Picard Medical Q3 2026 Net Loss Narrows 79% to $2.2 Million
  • Picard Medical's third-quarter 2026 net loss narrowed 79% to $2.2 million, while revenue fell 83% to approximately $200,000.
  • Gross profit turned positive at $100,000, while operating expenses decreased 35% to $2.2 million.
  • Cash totaled approximately $67,000 at September 30, 2026; additional financing is needed, with substantial doubt about its ability to continue operating.
  • The Emperor Total Artificial Heart drive system exceeded 18 million operating cycles in early reliability testing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611162210PRIMZONEFULLFEED9879161) on November 17, 2026, and is solely responsible for the information contained therein.